Lipids, Apolipoproteins, and the Risk of Parkinson Disease

Plasma urate and risk of Parkinson's disease: a Mendelian randomization study

(2018) Camilla J Kobylecki et al.   ANNALS OF NEUROLOGY

Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease

(2018) Demis A Kia et al.   ANNALS OF NEUROLOGY

Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study

(2018) Violetta Rozani et al.   MOVEMENT DISORDERS

Cohort Profile: The AMORIS cohort

(2017) Göran Walldius et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The serum apolipoprotein B and lipoprotein a were associated with Parkinson's disease in the Southeastern Han Chinese

(2017) J.C. Zhuang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci

(2017) Diana Chang et al.   NATURE GENETICS

Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson’s Risk

(2017) Lijun Zhang et al.   Frontiers in Neurology

Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

(2016) Jack Bowden et al.   GENETIC EPIDEMIOLOGY

Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements

(2016) Jian-Yong Wang et al.   Scientific Reports

Association between cigarette smoking and Parkinson’s disease: A meta-analysis

(2015) Xiao Li et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors

(2015) Stephen Burgess et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

(2015) Xuemei Huang et al.   MOVEMENT DISORDERS

LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

(2015) Brendan K Bulik-Sullivan et al.   NATURE GENETICS

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

(2014) Christine R. Swanson et al.   MOVEMENT DISORDERS

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

Discovery and refinement of loci associated with lipid levels

(2013) Cristen J Willer et al.   NATURE GENETICS

Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson’s Disease Patients

(2013) Qiang Wei et al.   PLoS One

Accuracy and Sensitivity of Parkinsonian Disorder Diagnoses in Two Swedish National Health Registers

(2012) Adina L. Feldman et al.   NEUROEPIDEMIOLOGY

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease

(2011) L Lim et al.   CELL DEATH AND DIFFERENTIATION

Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial

(2010) Adam D. Gepner et al.   AMERICAN HEART JOURNAL

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

(2008) Xuemei Huang et al.   MOVEMENT DISORDERS

Total cholesterol and the risk of Parkinson disease

(2008) G. Hu et al.   NEUROLOGY